12/8/2013 10:01:16 AM
The Buffalo News: Partners for Buffalo $250 million biotech project opening in February
The Buffalo News
The $250 million drug development project announced a year ago for the Buffalo Niagara Medical Campus is on track to open a small-scale local operation by February.
In addition, the plan to bring Albany Molecular Research Inc. to the campus, hailed as part of Gov. Andrew M. Cuomo’s “Buffalo Billion” economic development campaign, has evolved with a second company also now committed to locate here, sources confirmed.
PerkinElmer, a Massachusetts company with 7,500 employees and $2 billion in annual revenue, will join AMRI as a partner and together become the first two companies to open local offices. The state is investing $50 million to build and equip a high-tech, drug-development facility for them on the campus.
Cuomo revealed the outline of the AMRI project last December, and academic, business and government leaders spent the past year firming up those plans and figuring out where on the medical campus to put AMRI and its partner.
The companies will move into temporary space at the Jacobs Neurological Institute, where a small contingent of researchers will work while permanent space for AMRI and PerkinElmer is built within a Ciminelli Real Estate Corp. facility already under construction, state and medical campus officials told The News.
“You’ll have the most advanced drug delivery and discovery lines buzzing with 250 high-tech researchers, innovators, for two top companies in the business,” said Alain E. Kaloyeros, senior vice president and CEO of SUNY Albany’s College of Nanoscale Science and Engineering, who is a driving force behind the AMRI project.